سعر دكستروز 5% وصوديوم كلورايد 0.9% اوتوسوكا محلول وريدي 250 مل 2026

Otsuka sterile IV infusion dextrose 5% with sodium chloride 0.9%, 250 ml (Egyptian sheet name).

• Parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride as required by the clinical condition of the patient (US Dextrose and Sodium Chloride Injection).Population: As clinically requiredDailyMed (U.S. NLM)

• May include febrile response, infection at injection site, venous thrombosis/phlebitis, extravasation, and hypervolemia (US labeling).International label, same formulation · DailyMed (U.S. NLM)

• US Fresenius Dextrose and Sodium Chloride Injection labeling states no known contraindications; clinical judgment still required (e.g., fluid overload states).International label, same formulation · DailyMed (U.S. NLM)

• Use solutions containing sodium ions with great care in congestive heart failure, severe renal insufficiency, and edema with sodium retention. Excessive potassium-free solutions may cause significant hypokalemia. Fluid/solute overload risk (US labeling).International label, same formulation · DailyMed (U.S. NLM)

• IV additivesAdditives may be incompatible; consult pharmacist; use aseptic technique and mix thoroughly; do not store after mixing (US labeling).DailyMed (U.S. NLM)

• Animal reproduction studies not conducted with dextrose or sodium chloride per this US label; unknown whether fetal harm can occur — give to a pregnant woman only if clearly needed.International label, same formulation · DailyMed (U.S. NLM)

• Dextrose: Provides carbohydrate calories and free water when given IV; metabolized via glycolysis.
• Sodium chloride: Provides sodium and chloride ions to restore extracellular fluid volume and electrolyte balance.